Background-Gain-of-function mutations in the voltage-gated sodium channel (Nav1.5) are associated with the long-QT-3 (LQT3) syndrome. Nav1.5 is densely expressed at the intercalated disk, and narrow intercellular separation can modulate cell-to-cell coupling via extracellular electric fields and depletion of local sodium ion nanodomains. Models predict that significantly decreasing intercellular cleft widths slows conduction because of reduced sodium current driving force, termed "self-attenuation." We tested the novel hypothesis that self-attenuation can "mask" the LQT3 phenotype by reducing the driving force and late sodium current that produces early afterdepolarizations (EADs). Methods and Results-Acute interstitial edema was used to increase intercellular cleft width in isolated guinea pig heart experiments. In a drug-induced LQT3 model, acute interstitial edema exacerbated action potential duration prolongation and produced EADs, in particular, at slow pacing rates. In a computational cardiac tissue model incorporating extracellular electric field coupling, intercellular cleft sodium nanodomains, and LQT3-associated mutant channels, myocytes produced EADs for wide intercellular clefts, whereas for narrow clefts, EADs were suppressed. For both wide and narrow clefts, mutant channels were incompletely inactivated. However, for narrow clefts, late sodium current was reduced via selfattenuation, a protective negative feedback mechanism, masking EADs. Conclusions-We demonstrated a novel mechanism leading to the concealing and revealing of EADs in LQT3 models.
T he long-QT type 3 (LQT3) syndrome is associated with gain-of-function mutations in the gene encoding the cardiac voltage-gated sodium (Na + ) channel (Nav1.5). In isolated myocytes, this gain-of-function generates a late Na + current that reproducibly triggers early afterdepolarizations (EADs). 1, 2 However, LQT3 can also be a concealed disease, 3, 4 requiring some other pathogenesis to unmask it, consistent with the relative difficulty of producing EADs in intact tissue. [5] [6] [7] The observation that LQT3-associated EADs are easier to produce in isolated myocytes than tissue has led to the hypotheses that gap junction coupling reduces action potential (AP) dispersion and prevents EAD propagation, 7 presumably by increased current sink into neighboring nondepolarizing myocytes. Simulations suggest that reduced gap junction coupling can promote EAD formation in tissue, by reducing the total number of EAD-producing myocytes necessary for EAD propagation. 7 However, the main experimental evidence to support this mechanism is the fact that EADs are more rare in tissue preparations.
Recently, we and others demonstrated that Nav1.5 [8] [9] [10] [11] [12] [13] and Na + current 14, 15 are enhanced in the intercalated disk (ID). Furthermore, we suggested that the narrow intercellular separation in Nav1.5-rich nanodomains could modulate electric coupling via localized extracellular ion-mediated effects, also termed ephaptic coupling (EpC). 10, [16] [17] [18] Although there are multiple proposed mechanisms of EpC, 18 this study focuses on 2 mechanisms: (1) extracellular electric fields: Na + channels in the depolarizing cell decrease the ID cleft potential, depolarizing the apposing membrane from the extracellular rather than the intracellular domain and (2) local Na + ion depletion: dynamic alteration of Na + concentration in the extracellular cleft alters the driving force of individual Na + ions.
See Editorial by Belardinelli et al
Importantly, computational models of EpC suggest that conduction velocity (CV) is biphasically related to EpC. 10, 16, 17, 19 In tissue with narrow intercellular cleft separations, conduction is modulated by a phenomenon termed "self-attenuation," 10, 20 whereby decreased intercellular separation slows conduction by two mechanisms: (1) an increase in downstream transmembrane potential at the ID (V m disk ) and
Revealing the Concealed Nature of Long-QT Type 3 Syndrome
Amara Greer-Short, PhD; Sharon A. George, PhD; Steven Poelzing, PhD; Seth H. Weinberg, PhD Revealing Long-QT-3 Syndrome (2) Na + ion depletion from the intercellular cleft, reducing the sodium reversal potential (E Na disk ). Both mechanisms attenuate Na + current (I Na disk ) driving force, reducing peak I Na disc , and thus reduce CV.
In this study, we tested the novel hypothesis, both ex vivo and in silico, that the concealed nature of LQT3 in intact tissue can arise from self-attenuation. Critically, in the concealed phase of the disease, despite conductive Na + channels, late I Na disk is significantly reduced because of attenuated driving force, suppressing EADs.
Methods
All animal study protocols were approved by the Institutional Animal Care and Use Committee (IACUC) at the Virginia Polytechnic University. Optical voltage mapping of Langendorff perfused hearts has been extensively described by the Poelzing laboratory. 8, 21 Full details of optical mapping and statistical analyses are provided in the Methods section in the Data Supplement. In brief, the anterior epicardial surfaces of the left and right ventricles from retired breeder guinea pigs were mapped during pacing. Late Na + current agonist, 22 sea anemone venom ATXII (7 nmol/L), was perfused into hearts at a concentration previously demonstrated to prolong AP duration (APD), without apparently producing EADs in guinea pigs. 23 Mannitol (26.1 g/L) was perfused to produce acute interstitial edema (AIE) 24 and intercellular expansion in the gap junction adjacent perinexus. 8 We recognize that edema is a complex clinical pathology involving intra and extracellular volume expansions. Transmission electron microscopy was performed as previously described 20, 25, 26 on 3 hearts per treatment. Additional details can be found in the Methods section in the Data Supplement.
The total number of experiments for each intervention was as follows: control 12, mannitol 5, ATXII 7, ATXII and mannitol 7. Data are presented as mean±SE unless otherwise noted, and P<0.050 was considered statistically significant.
Full details of the computational model are given in the Methods section in the Data Supplement. In brief, individual myocytes were coupled via gap junctions and EpC in a 50-cell linear strand ( Figure 1A) , as in the EpC model in Kucera et al. 10 Cells were discretized into 10 axial membrane patches and 2 in ID membrane patches, such that, unless otherwise stated, 90% of Na + channels were localized in the ID patches. A T-shaped network of cleft axial resistances and a radial resistance, proportional and inversely proportional, respectively, to the intercellular cleft width (w), governed extracellular potentials at the disk and cleft. ID Na + currents and diffusion with the bulk extracellular space governed the extracellular cleft Na + ion concentration ([
] Na
+ e cleft ) dynamics, which also depended on the cleft volume (proportional to the cleft width), ( Figure 1B ). A Markov model of an LQT3-associated Na + channel mutant, 27, 28 shown to produce a late Na + current (I Na ), was incorporated into a recent ventricular guinea pig myocyte ionic model. 29, 30 The mutant channel model exhibited 2 modes of gating, a "background mode" and a "burst mode," the latter of which represents a population of channels that transiently fail to inactivate ( Figure 1C ). Model parameters are given in Tables I and II in 
Results

Ex Vivo
The focus of our study was to investigate arrhythmogenic consequences of modulating ID width in an LQT3 model of cardiac tissue. We first tested the hypothesis that ID expansion can prolong APD and unmask EADs in a drug-induced, guinea pig model of LQT3. Representative transmission electron microscopy micrographs and summary data from a blinded observer demonstrated that intercellular separation (w P ) within the perinexus (Figure 2A) Optical mapping experiments revealed that increasing w P with mannitol alone ( Figure 2B , AIE, green) did not significantly change APD90, regardless of cycle length (CL) relative to control ( Figure 2B ; Table III in the Data Supplement, black; P=0.141, at CL=500 ms, 165±3 ms; 95% CI, 153-177 ms versus 177±10 ms; 95% CI, 152-203 ms, AIE versus control, respectively). When hearts were perfused with ATXII (blue) to pharmacologically induce LQT3, APD90 was statistically greater at multiple CLs, and the APD restitution curves diverged at greater CLs ( Figure 2B ; Table III in the Data Supplement, P=2.61e-4, at CL=500 ms, ATXII 249±7 ms; 95% CI, 231-266 ms), consistent with previous studies demonstrating that bradycardia exacerbates APD prolongation during acquired LQT3. 22, 27 Furthermore, ATXII+AIE (red) increased APD relative to ATXII alone, and the ATXII+AIE restitution profile diverged from ATXII ( Figure 2B ; Table  III in the Data Supplement, P=0.0140, at CL=500 ms, ATXII+AIE 307±19 ms; 95% CI, 257-356 ms). This can be seen more clearly in Figure 2C , where the proportional APD increase from ATXII to ATXII+AIE at CL=160 ms was 6±1% (95% CI, 5%-8%). Increasing the CL to 600 ms further and significantly increased this proportionality relative to 160 ms (P=0.0494, 30±12%; 95% CI, 8%-38%). In addition, a regression analysis revealed that ATXII and ATXII+AIE significantly increase APD restitution slope, compared with
WHAT IS KNOWN
• The LQT3 syndrome is a concealed disease that is associated with gain-of-function mutations in the gene encoding the cardiac voltage-gated sodium channel.
• This gain-of-function generates a late sodium current that consistently triggers arrhythmogenic EADs in isolated myocytes. However, EADs are harder to reproduce in cardiac tissue.
WHAT THE STUDY ADDS
• In computational and experimental LQT3 models, increasing intercellular separation in sodium channel-rich ID nanodomains can prolong APs and promote EADs, whereas narrow intercellular separation can conceal the LQT3 phenotype and suppress EADs.
• LQT3 masking occurs because of negative feedback from the late sodium current localized at the ID that depletes the sodium concentration in the intercellular cleft. Revealing Long-QT-3 Syndrome control, whereas there is no difference for AIE alone (Table IV in the Data Supplement).
We further assessed arrhythmic burden in our guinea pig model of LQT3 by quantifying the proportion of hearts that had at least 1 R-on-T event 31 during the last 20 minutes of the intervention, determined by a QRS complex occurring at a time corresponding to the last nonectopic beat's T-wave measured from the volume conducted bath ECG ( Figure 2D ). R-on-T Revealing Long-QT-3 Syndrome events never occurred during control or AIE. Importantly, ATXII+AIE was associated with significantly more R-on-T events relative to control (P=0.027, 57% versus 0%). As optical mapping is limited to the anterior epicardial field of view, it was not possible to determine the mechanism of R-on-T phenomenon for every event. However, we could observe a secondary depolarization, that is, an EAD, before complete repolarization of the preceding AP ( Figure 2D ).
These results are the first demonstration that low-concentration ATXII and mannitol-induced AIE together during bradycardia unmasked significant APD prolongation and a more severe drug-induced LQT3 phenotype, compared with ATXII alone. Furthermore, consistent with our previous work, 20, 25, 26 transmission electron microscopy micrographs illustrate the spatially restricted nature of intercellular clefts ( Figure 2A ). The high density of Na + channels localized at the ID suggests that extracellular cleft Na + depletion may be an important aspect of Na + -dependent signaling and demonstrates the need for computational modeling to account for the time-dependent dynamics of Na + influx, efflux, and diffusion at the intercellular cleft, especially in pathological settings of Na + channel mutations.
In Silico
We next performed simulations in a strand of myocytes that contain an LQT3-associated Na + channel mutant (Y1795C) to identify the mechanism for EAD unmasking during intercellular cleft expansion and EAD suppression during cleft narrowing. Myocytes were paced at a 1000-ms CL at one end of the strand. Figure 3 Wild-type (WT) cells did not produce EADs in strands with either narrow (w=10 nm, dashed black) or wide (w=50 nm, green) clefts ( Figure 3A) , and there was no difference between APDs. APD was prolonged with Y1795C mutant myocytes in strands with both narrow (blue) and wide clefts (red). However, even with the mutation, myocytes in narrow cleft strands did not generate EADs, whereas mutant myocytes in wide cleft strands produced EADs on every other beat.
Sodium Channel Open Probability, Current, and Reversal Potential
To explore the theoretical mechanisms of EAD formation in strands, Na + channel open probability, current, and reversal potential were tracked during the AP. p open Na disk , increased with the Y1795C mutation in narrow cleft strands as expected (Figure 3B, blue) . As the AP repolarized, the late I Na disk increased ( Figure 3C, blue) . Importantly, we observed interesting dynamics that prevented EAD formation in narrow cleft strands. Narrow cleft strands supported EpC, promoting 2 critical phenomena: first, E Na disk was reduced in mutant narrow cleft strands immediately after the AP upstroke because of depleted [ ] Na + e cleft ( Figure 3D , blue, arrow 1), which decreased the late I Na disk compared with mutant wide cleft strands ( Figure 3C, cleft was not depleted to the same extent as occurred in narrow cleft strands. In short, E Na disk was larger in the mutant wide cleft width strands immediately after the AP upstroke ( Figure 3D, red) 
APD and Cleft Width
APD is shown as a function of cleft width in WT (black) and mutant (red) strands during 1000-ms CL pacing in Figure 4A . In WT strands, APD did not depend on cleft width. However, in mutant strands, EADs were unmasked for cleft widths >20 nm. APD increased as cleft width increased, with "jumps" at irregular intervals, corresponding to increasingly longer EADs.
APD and CL
The above experiments only discussed the mechanisms of EAD suppression and formation at a 1000-ms CL. However, bradycardia is known to exacerbate arrhythmogenic risk in LQT3. Therefore, we explored the CL-dependence of APD as well ( Figure 4B ). In WT strands, APD gradually increased as CL increased, with negligible difference between wide (green) and narrow (black) strands, consistent with typical APD restitution.
In narrow mutant strands ( Figure 4B , blue), APD was slightly longer compared with WT, and only at very long CLs Figure 3 and restitution curves in B and D. The maximum APD and CV over the final 4 beats, after pacing to steadystate, are plotted to account for beat-tobeat variation. Revealing Long-QT-3 Syndrome more than ≈1700 ms were EADs unmasked. EAD formation at very long CLs in mutant narrow cleft strands occurs via increased [ ] Na
+ e cleft refilling after long diastolic intervals because of both pump and exchanger activity and extracellular diffusion while the Na + channels are nonconductive. In wide mutant strands (red), at shorter CLs less than ≈900 ms, APD was also longer compared with narrow mutant strands, but EADs did not form because [ ] Na
+ e cleft was insufficient to sustain the elevated E Na disk required for significant late I Na disk . However, for longer CLs more than ≈900 ms, EADs were unmasked, and APD increased greatly as CL increased. Importantly, the model predicts that modulating [ ] Na
+ e cleft accumulation may be a new mechanism underlying EAD formation in LQT3, independent of the mutant channel kinetics.
Conduction and Cleft Width
Although the relationship between conduction and intercellular separation within the ID is the subject of numerous computational studies, 10, 17, 32 this relationship has not been explored for Na + channel gain-of-function mutations. CV is shown as a function of cleft width in WT (black) and mutant (red) strands during 1000-ms CL pacing ( Figure 4C ). In both WT and mutant strands, CV had a biphasic dependence. For cleft widths between 10 and 50 nm, CV decreased as cleft width increased, as EpC was reduced, consistent with our previous experimental data. 8, 24 For narrow clefts, CV decreased as cleft width decreased because of electric field-induced self-attenuation, also consistent with our recent experimental report. 20 The model predicts the Y1795C mutation slightly increased CV relative to WT at clefts widths >20 nm and <10 nm. However, in the nominal cleft width range found in guinea pig and mouse ventricular tissue (10-20 nm), 8, 26 CV is predicted to be relatively similar for WT and mutant strands.
Conduction and CL
The predicted relationship between CV and CL is equally interesting ( Figure 4D ). Relative to wide cleft strands (Figure 4D , red and green), CV restitution in narrow strands (blue and black) was broader, that is, CV decreased over a wider range of CLs. In particular, CV at CLs <500 ms was slower in narrow cleft strands (black and blue) than in wide cleft strands (green and red). This finding did not depend on the type of sodium channel (WT or Y1795C). Yet, the opposite occurred at higher CLs >500 ms, where CV was greater in the narrow (black and blue) relative to wide cleft strands (green and red), as in Figure 4C . CV was reduced to a greater extent at short CLs in narrow strands because electric field-induced selfattenuation of peak I Na disk is greater, relative to longer CLs.
Effects of CL and Cleft Width
The above analyses considered cleft width and CL individually to demonstrate how each affects APD and CV. We next explored the broader relationship between APD, CV, CL, and cleft width in mutant myocyte strands ( Figure 5 ). For all CLs, APD increased as cleft width increased ( Figure 5A ). As in Figure 4 , at long CLs, CV was a biphasic function of cleft width, whereas at short CLs, CV increased as cleft width increased because of a release from EpC electric field-induced self-attenuation ( Figure 5B) . Interestingly, at a CL of ≈500 ms, CV was nearly independent of cleft width. We superimposed the CV measurements and regimes for EADs and no EADs ( Figure 5C ). Critically, we found that as the cleft width narrows, EADs were masked at longer CLs. Collectively, these results suggest that EpC and self-attenuation alter conduction and mask EADs in a complex manner, dependent on both cleft width and CL. In narrow cleft strands (w<10 nm) or during fast pacing (CL<500 ms), both peak and late I Na disk are greatly reduced because of self-attenuation, such that conduction slows and EADs are masked. In strands with wider clefts (w>10 nm) and during slower pacing (CL>500 ms), the influence of self-attenuation on peak I Na disk is less pronounced, such that conduction slowed as cleft width increased because of reduced EpC. However, the influence of selfattenuation on late I Na disk was still significant, such that EADs were masked for sufficiently narrow clefts (for CL > ≈900 ms). As CL increased, providing more recovery time between beats, the late I Na disk was no longer sufficiently reduced, and EADs were unmasked in narrower cleft strands. Importantly, our simulations predict that because of the large disparity in amplitude between peak and late I Na disk , a range of cleft widths and CLs exists in which EpC both promotes normal conduction and masks EADs. cleft depletion is critical to the ionic self-attenuation mechanism that reduced the late I Na disk and masked EADs. To probe the contribution of electric field coupling, the extracellular T-shaped resistor network ( Figure 1A ) was removed such that an extracellular potential could not develop at the ID, that is, ϕ e cleft and ϕ e disk were fixed at 0. When electric field coupling was removed (red), EADs were still masked in narrow cleft width strands. APD in mutant myocyte strands with (blue) and without electric field coupling (red) were close for all cleft widths ( Figure 6B ). However, without electric field coupling, CV monotonically increased as a function of cleft width (Figure 5C, red) , further supporting previous conclusions that electric field coupling mediates the CV decrease at wider cleft widths. Both clamping [ ] Na
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+ e cleft and removing electric field coupling resulted in no CV dependence on cleft width (magenta), as EADs were unmasked and CV was a constant for all cleft widths.
We performed several additional simulations to identify the critical factors necessary for concealing EADs in LQT3. To match the CV decrease previously observed in experiments as cleft width increases, 8, 24 the gap junction conductance value from the Kucera et al. 10 EpC model was reduced. Importantly, we found that the negative feedback mechanism for EAD suppression did not depend on gap junction conductance, as reduced gap junctional coupling only slightly Revealing Long-QT-3 Syndrome altered the APD dependence on cleft width ( Figure III in the Data Supplement). Next, we found that high Na + channel ID localization was required to mask EADs in narrow cleft strands because lateral membrane localized Na + channels, exposed to an invariant [ ] Na + e bulk , did not drive the negative feedback necessary to suppress the late Na + current ( Figure IV in the Data Supplement). Furthermore, we showed that EADs were suppressed in a myocyte strand with nonjunctional restricted extracellular spaces, consistent with [ ] Na + e cleft depletion simulations in Figure 6 ; however, EADs were masked over a smaller extracellular volume range in myocyte strands with nonjunctional extracellular spaces, compared with cleft spaces because of the absence of high Na + channel junctional localization ( Figure V in the Data Supplement). Parameter studies varying the transition rates in the sodium channel Markov model showed that the transition rates between the "background mode" and "burst mode"
were primarily responsible for prolonging APD and promoting EADs in myocyte strands with wide clefts ( Figure VI Finally, simulations demonstrated that the protective mechanism underlying EAD masking in strands with narrow cleft width was similarly robust in a different LQT3-associated sodium channel mutant (I1768V; Figure VIIA in the Data Supplement) and different species (canine, Figures VIIB and VIIC in the Data Supplement). Importantly, the mechanism underlying the late Na + current in the 2 mutant types are distinct: Y1795C mutant channels fail to inactivate 27 and I1768V mutant channels exhibit a faster inactivation recovery that facilitates channel reopening 28 ; neither mutant channel presents with steady-state channel reopening nor "window current." Thus, simulations demonstrated that masking EADs did not depend on the specific molecular mechanism underlying the late Na + current. 
Discussion
In this study, we demonstrated a novel mechanism leading to the formation of EADs in the long-QT type 3 syndrome, findings supported by a guinea pig acquired LQT3 model. This new mechanism may operate independent of the type of specific mutation associated with LQT3 and the underlying channel dysfunction producing the late Na + current. Both experiments and simulations demonstrated that increasing intercellular separation in Na + channel-rich ID nanodomains can exacerbate APD prolongation in LQT3, leading to arrhythmogenic EADs. The proposed mechanism by which narrow intercellular clefts conceal LQT3 is related to the depletion of [ ] Na
+ e cleft , an ionic self-attenuation mechanism. In summary, I Na disk reduces E Na disk via the depletion of the local [ ] Na
+ e cleft , which, in turn, reduces I Na disk via a negative feedback mechanism. Taken together, the experimental and computational results suggest that bradycardia and extracellular volume expansion in the ID can unmask an arrhythmogenic LQT3 phenotype, whereas an LQT3 mutation or ID expansion individually only produce modestly abnormal electrophysiological behavior.
Previous computational modeling studies have provided valuable insights into the cellular mechanisms, leading to APD prolongation and EADs during bradycardia in myocytes with LQT3-associated mutations.
2,27,28 Clancy et al 27 demonstrated that the amount of time mutant channels spend bursting (burst mode dwell time) may be the primary determinant of the inverse heart-rate dependence of the sustained late Na + current. At fast heart rates, despite the presence of a large late Na + current, relative to WT myocytes, APD was minimally prolonged because of incomplete deactivation of the slow-component of the delayed rectifier K + channel I Ks . At slower heart rates, sufficient time between beats allowed for complete deactivation of I Ks , shifting the balance of depolarizing and repolarizing currents and significantly prolonging APD. Furthermore, simulations have illustrated that while the late Na + current triggers EADs, the depolarizing current driving EADs is carried by the L-type Ca 2+ channel. 33 The late Na + current prolongs the AP sufficiently long to allow for recovery from inactivation and reactivation of the L-type Ca 2+ channel. Simulations of therapies directly targeting the Na + channel have been used to predict the efficacy of various pharmacological treatments. [34] [35] [36] [37] [38] Vecchietti et al 35 illustrated that reducing Na + and Ca 2+ current conductances suppressed EADs in LQT3-associated mutant myocytes. More recent studies have highlighted the importance of drug binding kinetics, including drugs with state-specific binding sites. Clancy et al 34 predicted that open-state channel blockers are more efficacious in LQT3-associated ΔKPQ mutant channels, which have longer channel mean open times due to abnormal burst mode gating, compared with WT channels. In contrast, inactivatedstate channel blockers are less effective in suppressing EADs and may adversely affect conduction by reducing peak I Na . Moreno et al 36 performed an in silico screening of ranolazine in myocytes with ΔKPQ mutant channels. Ranolazine not only exhibits preferential block of late Na + current relative to peak Na + current but also blocks the rapid component of the delayed rectifier K + current I Kr . Simulations predicted that ranolazine suppresses bradycardia-and pause-induced EADs and does not reduce CV, findings independent of the specific myocyte ionic model used in the simulation.
Computational studies have also played an integral role on elucidating arrhythmogenic mechanisms in the interactions between intracellular signaling cascades and Na + channel regulation. Simulation of β-adrenergic agonists in myocyte strands with ΔKPQ mutant channels was predicted to suppress EADs and reduce transmural dispersion of repolarization because of increased peak I Ks and I Kr . However, the β-blocker propranolol, in combination with isoproterenol, was predicted to prolong APD in low doses and shorten APD in high doses, suggesting the need for dose-controlled clinical trials for LQT3 patients using β-blockers. 38 A recent study by Koval et al 37 found that 2 different SCN5A mutants led to aberrant phosphorylation by Ca 2+ /calmodulin-dependent protein kinase II, enhancing the late Na + current and increasing susceptibility to EADs.
Importantly, while many of the aforementioned simulation studies were performed in 1-, 2-, or 3-dimensional tissues (however, neglecting EpC and cleft Na + nanodomains), the mechanism underlying EAD formation involved the balance of Ca 2+ , K + , and Na + currents at the level of the individual myocytes. Furthermore, drug therapies typically targeted specific ionic currents: suppressing the late Na + current by reducing channel conductivity or the channel open probability via increased dwell-time in nonconductive drug-bound state(s) or augmenting compensatory repolarizing currents via activation of intracellular signaling cascades. Critically, our results do not contradict the findings or interpretations discussed above. Instead, we provide an additional important mechanism that explains why EADs form particularly at slow heart rates in tissue, and we provide evidence that nanodomain cleft [Na + ] modulation is a novel mechanism to unmask EAD formation at these slow heart rates. Taken together, our current work and previous studies suggest that LQT3 patients may be at highest risk of lethal ventricular arrhythmias under conditions associated with bradycardia and extracellular edema as occurs with cardiac surgery, 39 ischemia, 40 or heart failure. 41 Furthermore, future therapies aimed at reducing lethal arrhythmias in LQT3 could target reducing extracellular volume, a novel therapeutic approach that reduces late Na + current in the ID but does not alter Na + channel gating or activate intracellular signaling cascades (with potentially many off-target effects), as a complement or alternative to Na + channel or other targeting therapies.
EpC in cardiac tissue has been investigated in previous computational studies 10, 16, 17, 19, 32 and recently by us experimentally. 8, 20, [24] [25] [26] 42 These studies have typically focused on how EpC influences conduction and is modulated by gap junctional coupling, extracellular ionic concentrations, and other factors. Our findings agree with previous studies demonstrating that intercellular cleft width and Na + channel localization are critical parameters regulating activation and conduction in cardiac tissue. 16, 17 To our knowledge, our current study is the first to demonstrate the importance of these properties in regulating repolarization in the setting of an arrhythmogenic mutation and further showing a potentially protective mechanism in which EpC, and in particular cleft Na + depletion, can suppress EAD formation. Revealing Long-QT-3 Syndrome
Limitations
Although our experimental results support computational predictions, the experiments are not without limitations. As with all studies relying on pharmacological agents, both ATXII and mannitol may have underappreciated off-target effects individually and collectively. Experiments do not provide direct proof for intercellular cleft Na + ion depletion. The observation that the experiments are well-described by a robust computational model is supporting evidence that incorporating extracellular electric field and cleft Na + ionic coupling into a model can reproduce a diverse experimental data set, including the responses of cardiac conduction, APD restitution, and EAD formation to the late I Na augmenting effects of ATXII and the perinexal cleft expanding effects of mannitol. We do not claim that this constitutes proof that perinexal cleft expansion is the primary mechanism of an unmasked LQT3 phenotype. Rather, models and experiments well describe each other, and these theories can generate new ideas to treat this complicated disease.
Although our computational model reproduces important aspects of electric conduction, it is not without limitations. Our model represents a 1-dimensional (1D) myocyte strand and thus does not account for the complex 3D structure of cardiac tissue. Furthermore, our model does not account for the 3D geometry of the individual myocyte, as in the electrodiffusion model of Mori et al. 17 However, modeling Na + channel localization and intracellular electrical propagation with a detailed biophysical ionic model necessitated a numerical integration time step (0.05 μs) on the order of 1000× smaller than recent 2D and 3D tissue computational studies. As such, our model represents a compromise between computational cost and the level of subcellular and extracellular discretization necessary to account for critical biophysical details, as expanding to increasing dimensionality at either the cellular or tissue level would have been computationally challenging. In addition, model parameters for the cleft nanodomain were tuned to match experimental trends. Species differences between the sodium channel Markov models 27, 28 (fitted to patch clamp measurements of recombinant Na + channels in human embryonic kidney 293 cells) and the ionic models (representing guinea pig 30 and canine 29 ventricular myocytes) may introduce differences between experimental and computational results. Finally, further studies are needed to determine to what extent ID localization of ion pumps, exchangers, and other ion channels and depletion or accumulation of other intercellular cleft ions (eg, potassium, calcium, and chloride) influence EAD suppression during LQT3. Nonetheless, these limitations do not detract from the critical prediction of a novel mechanism underlying the concealment of the LQT3 phenotype.
